Xakeli is a cutting-edge and epoch-making drug in the field of targeted treatment of lung cancer

Xacrel is a cutting-edge and epoch-making drug in the field of targeted treatment of lung cancer


Xacrel, chemically named crizotinib, is a targeted drug for non-small cell lung cancer.
The so-called targeted therapy is to prescribe the right medicines for different molecular mutations to avoid the ineffective killing of normal cells like chemotherapy and radiotherapy. Targeted therapy drugs, including Xercoride, Rocaine, Iressa, etc., target different targets (the mutated molecules mentioned earlier). Relevant testing should be carried out before use to confirm the target. Use anti-drugs to concentrate firepower. For example, the target of Xalkri is a fusion gene. For positive patients, Xalkri's disease control rate is as high as %, which significantly prolongs the patient's survival and greatly reduces the patient's pain during treatment.
Secret is a cutting-edge and epoch-making drug in the field of targeted treatment of lung cancer and is used as a first-line drug for positive patients. At present, it has not been officially launched in China, so there are relatively few patients who have used it. In the next month, hospitals in major cities in China will be able to prescribe this drug, which will benefit more positive patients.

Address: Zhongguancun Building, Beisihuan Middle Road, Haidian District, Beijing
Company name: Beijing Mingkang Trading Co., Ltd.
Telephone:
Number:
Contact Person: Miss Chen